RFG
MED icon

Range Financial Group’s Medifast MED Stock Holding History

Range Financial Group’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5,327
Closed -$399K – 173
2023
Q3 		$399K Sell
5,327
-1
-0% -$89 0.26% 112
2023
Q2 		$491K Sell
5,328
-126
-2% -$11.2K 0.31% 107
2023
Q1 		$565K Sell
5,454
-151
-3% -$16.7K 0.37% 97
2022
Q4 		$647K Buy
+5,605
New +$653K 0.44% 96
2022
Q3 		– Sell
-7,733
Closed -$1.4M – 159
2022
Q2 		$1.4M Sell
7,733
-319
-4% -$57.1K 1.01% 26
2022
Q1 		$1.38M Buy
8,052
+412
+5% +$77.7K 0.88% 36
2021
Q4 		$1.6M Buy
7,640
+396
+5% +$81.9K 1.05% 25
2021
Q3 		$1.4M Sell
7,244
-218
-3% -$53.6K 1% 29
2021
Q2 		$2.11M Buy
7,462
+493
+7% +$134K 1.56% 10
2021
Q1 		$1.48M Buy
+6,969
New +$1.67M 1.34% 18

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Range Financial Group's MED Position: Q4 2023 in Review

Range Financial Group sold out of Medifast (MED) in Q4 2023, closing a stake of 5,327 shares — an estimated $399K sold.

Range Financial Group first reported a position in MED in Q1 2021 and held it in 10 quarters. The position peaked at $2.11M in Q2 2021. 216 funds tracked by Wall St. Rank hold MED as of Q4 2023.

  • Range Financial Group reported no remaining Medifast position as of Q4 2023 after selling out during the quarter.
  • Range Financial Group sold 5,327 Medifast shares in Q4 2023, an estimated $399K.
  • Range Financial Group first reported a position in Medifast in Q1 2021 and held it in 10 quarters.
  • Range Financial Group's Medifast position peaked at $2.11M in Q2 2021.
  • 216 funds tracked by Wall St. Rank held Medifast as of Q4 2023.

Based on Range Financial Group's 13F filing for Q4 2023, filed 10 Jan 2024.